Overview
Watchlist
Equities
Crypto
Soon
Popular
Home
Equities
NAVB
Fundamentals

Navidea Biopharmaceuticals, Inc.

NAVB

Chart
Fundamentals
Soon
Sentiment
Soon
Options

Revenue

0.00
0.000.00%
3 Months Change

Assets

5.70M
▼-2.52M▼-30.67%
3 Months Change

Liabilities

8.68M
▼-327.56k▼-3.64%
3 Months Change

Free Cash Flow

-1.74M
▲860.94k▲33.14%
12 Months Change

Revenue/Cost Of Revenue

Net Profit/Loss

Assets/Liabilities

Cash Flows

Earnings Per Share

Outstanding Shares

Recent Quarterly and Annual Filings

2023-12-01
Form 8-K
ID: 0001437749-23-033343
2023-11-16
Form 8-K
ID: 0001437749-23-032354
2023-11-14
Form 10-Q
ID: 0001437749-23-032052
2023-08-11
Form 10-Q
ID: 0001437749-23-023319
2023-08-08
Form 8-K
ID: 0001437749-23-022524
2023-07-28
Form 8-K
ID: 0001437749-23-021059
2023-07-13
Form 8-K
ID: 0001437749-23-019901
2023-07-06
Form 8-K
ID: 0001437749-23-019502
2023-06-16
Form 8-K
ID: 0001437749-23-017746
2023-06-16
Form 8-K
ID: 0001437749-23-017745